CNQ vs CSAN

CNQ demonstrates exceptional fundamental strength, anchored by a Piotroski F-Score of 8/9 and a superior ROE of 25.81% that dwarfs the sector average. While the current price of $44.24 is slightly above the Graham Number ($36.37), it trades at a massive discount to its growth-based intrinsic value of $111.22. Despite a bearish technical trend (0/100), the company's low P/E ratio and sustainable dividend payout provide a significant margin of safety. The explosive YoY earnings growth suggests high operational efficiency and cost management despite stagnant revenue growth.

CSAN exhibits severe financial distress as evidenced by a critical Piotroski F-Score of 2/9, indicating weak fundamental health. While the company maintains strong liquidity (Current Ratio 2.58) and impressive operating margins (30.71%), these are completely offset by a negative net profit margin of -24.05% and a catastrophic YoY EPS decline of -712.5%. The stock is in a long-term technical downtrend, losing over 72% of its value over five years, and consistently misses earnings estimates. Despite a low Price/Sales ratio, the negative ROE and poor earnings quality make the current valuation risky.